Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Ultrasound Assessment of Lumbopelvic Muscles in Men With Chronic Low Back Pain

10. november 2026 oppdatert av: Buse Sert, Medipol University

Ultrasonographic Evaluation of the Pelvic Floor and Lumbopelvic Stabilizer Muscles in Men With Chronic Nonspecific Low Back Pain

This study aims to evaluate the pelvic floor and lumbopelvic stabilizer muscles (transversus abdominis, internal oblique, and lumbar multifidus) using ultrasonography in men with chronic nonspecific low back pain. Muscle morphology and activation will be assessed at rest and during different functional tasks to investigate potential alterations in muscle coordination and lumbopelvic stability. The findings may contribute to a better understanding of neuromuscular dysfunction and guide rehabilitation strategies.

Studieoversikt

Status

Har ikke rekruttert ennå

Detaljert beskrivelse

Low back pain is a major musculoskeletal health problem with a high lifetime prevalence and is one of the leading causes of disability worldwide (1). In most cases, no specific pathological cause can be identified, and the condition is classified as nonspecific low back pain (2). When pain persists for more than three months, it is defined as chronic nonspecific low back pain, which negatively affects individuals' functional capacity, quality of life, and work participation (3). Multiple biomechanical, neuromuscular, psychosocial, and behavioral factors are thought to contribute to the development and persistence of chronic nonspecific low back pain (3).

In recent years, the concepts of lumbopelvic stability and motor control have gained increasing attention in explaining the underlying mechanisms of chronic low back pain. Lumbopelvic stabilization is a dynamic system resulting from the coordinated interaction of the spine, pelvis, and surrounding soft tissues through neuromuscular control. This system depends not only on passive structures but also on active muscular control and central nervous system integration (4, 5). Within this functional system, the transversus abdominis, internal oblique, lumbar multifidus, diaphragm, and pelvic floor muscles are considered key stabilizers. Rather than functioning independently, these muscles work synchronously through co-activation to maintain dynamic spinal stability. Therefore, dysfunction in any of these muscle groups may affect not only the individual muscle but also the overall coordination of the lumbopelvic stabilization system (6).

Delayed activation, reduced muscle thickness, atrophy, and impaired motor control of the transversus abdominis and lumbar multifidus muscles have been reported in individuals with chronic nonspecific low back pain (7, 8). Furthermore, recent studies have highlighted that the pelvic floor muscles play an important role not only in continence but also in maintaining lumbopelvic stability (6, 9). The pelvic floor muscles work in coordination with the transversus abdominis, multifidus, and diaphragm to regulate intra-abdominal pressure and contribute to spinal stabilization mechanisms (10). Consequently, impaired pelvic floor muscle function has been suggested to contribute to inadequate load transfer, altered motor control, and pain in the lumbopelvic region.

Although electromyography is widely used to assess muscle function, rehabilitative ultrasonography has emerged as a reliable, valid, and noninvasive method for examining muscle morphology and activation characteristics (11, 12). Ultrasonography enables real-time assessment of changes in muscle thickness and functional responses during muscle contraction. Ultrasonographic measurements have demonstrated high reliability, particularly in evaluating the activation of the transversus abdominis, internal oblique, lumbar multifidus, and pelvic floor muscles (13, 14).

In the existing literature, the abdominal muscles, multifidus, and pelvic floor muscles have generally been investigated separately in individuals with chronic nonspecific low back pain (6, 15). However, studies simultaneously evaluating the functional behavior of the transversus abdominis, internal oblique, lumbar multifidus, and pelvic floor muscles, which are essential components of the lumbopelvic stabilization system, remain limited (16). This limitation prevents a comprehensive understanding of functional coordination and potential co-activation impairments among these muscles (6). Moreover, research investigating the ultrasonographic activation characteristics of these muscles in men at rest, during the abdominal hollowing maneuver, and during voluntary pelvic floor muscle contraction is insufficient.

This study aims to address an important gap in the literature by comprehensively evaluating the transversus abdominis, internal oblique, lumbar multifidus, and pelvic floor muscles within the same individuals under different functional conditions. While previous studies have predominantly examined these muscle groups separately, research assessing their functional behavior during rest and various activation tasks remains limited. Furthermore, most studies investigating the relationship between pelvic floor function and lumbopelvic stability have focused on female populations, resulting in insufficient ultrasonographic data regarding these muscles in men. Therefore, this study aims to investigate the functional synergy of lumbopelvic muscles in men with chronic nonspecific low back pain and contribute to the understanding of motor control mechanisms and the development of targeted clinical rehabilitation strategies.

Studietype

Observasjonsmessig

Registrering (Antatt)

40

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Büşra Yeşil, Asis. Prof. Dr.
  • Telefonnummer: +905452441047
  • E-post: dryesilll@gmail.com

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Mann

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

The study population will consist of 40 male participants aged 18-65 years recruited at Medicana Bursa Hospital, Türkiye. Twenty participants with chronic nonspecific low back pain lasting at least three months will constitute the patient group, and 20 age-comparable healthy males without low back pain during the previous six months will constitute the control group. Pelvic floor and lumbopelvic stabilizer muscle function will be assessed using ultrasonography.

Beskrivelse

Inclusion Criteria

Chronic Nonspecific Low Back Pain Group:

Male participants aged 18-65 years.

Chronic nonspecific low back pain lasting at least 3 months.

Body mass index (BMI) below 30 kg/m².

Ability to understand verbal instructions.

Willingness to participate voluntarily.

Provision of written informed consent.

Healthy Control Group:

Male participants aged 18-65 years.

No history of low back pain within the previous 6 months.

Body mass index (BMI) below 30 kg/m².

Ability to understand verbal instructions.

Willingness to participate voluntarily.

Provision of written informed consent.

Exclusion Criteria (Both Groups):

BMI ≥30 kg/m².

Regular sports exercise, core stabilization, Pilates, or pelvic floor exercises at least 3 days per week within the previous 6 months.

Employment involving heavy physical labor.

Specific spinal pathologies, including radiculopathy, spinal stenosis, spondylolisthesis, vertebral fracture, spinal infection, spinal tumor, or inflammatory spinal disease.

History of abdominal, pelvic, urinary tract, or lumbar surgery.

History of severe trauma affecting the lumbar region, pelvis, or lower extremities.

History of neurological disorders.

Urinary tract diseases, benign prostatic hyperplasia, urinary incontinence, or other urological conditions affecting pelvic floor function.

Umbilical or inguinal hernia.

Respiratory diseases associated with chronic cough.

Sacroiliac or hip joint pathologies.

Rheumatological, metabolic, or endocrine disorders affecting muscle function, such as diabetes mellitus or hypothyroidism.

History of malignancy.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: CASE_CONTROL
  • Tidsperspektiver: CROSS_SECTIONAL

Kohorter og intervensjoner

Gruppe / Kohort
Chronic Nonspecific Low Back Pain Group

Twenty male participants aged 18-65 years with chronic nonspecific low back pain will undergo ultrasonographic assessment of pelvic floor and lumbopelvic stabilizer muscles.

Healthy Control Group

Twenty age-comparable healthy male participants aged 18-65 years will undergo the same ultrasonographic assessments.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pelvic Floor Muscle Function Assessed by Ultrasonography
Tidsramme: Baseline (single assessment session)

Pelvic floor muscle function will be assessed using transabdominal ultrasonography by measuring bladder base displacement (mm) during voluntary pelvic floor muscle contraction and abdominal hollowing.

Baseline (single assessment session)
Lumbopelvic Stabilizer Muscle Thickness and Contraction Ratios
Tidsramme: Baseline (single assessment session)

ransversus abdominis, internal oblique, and lumbar multifidus muscle thickness (mm) will be measured using B-mode ultrasonography at rest, during abdominal hollowing, and during voluntary pelvic floor muscle contraction. Contraction ratios will be calculated as muscle thickness during activation divided by resting muscle thickness.

Baseline (single assessment session)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Functional Disability Assessed by the Oswestry Disability Index (ODI)
Tidsramme: Baseline (single assessment session)

Functional disability related to low back pain will be assessed using the Oswestry Disability Index (ODI). The total score will be expressed as a percentage (0-100%), with higher scores indicating greater disability.

Baseline (single assessment session)
Pain Intensity Assessed by the Numeric Rating Scale (NRS)
Tidsramme: Baseline (single assessment session)

Pain intensity will be assessed using an 11-point Numeric Rating Scale (0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. Participants with chronic low back pain will report their average pain intensity during the previous week.

Baseline (single assessment session)
Health-Related Quality of Life Assessed by EQ-5D-5L
Tidsramme: Baseline (single assessment session)

Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L), covering mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. General health status will also be assessed using the EQ VAS (0-100).

Baseline (single assessment session)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

10. november 2026

Primær fullføring (Antatt)

10. mai 2027

Studiet fullført (Antatt)

10. juli 2027

Datoer for studieregistrering

Først innsendt

10. november 2026

Først innsendt som oppfylte QC-kriteriene

10. november 2026

Først lagt ut (Faktiske)

16. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. november 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere